Abstract | CONTEXT: OBJECTIVE: To describe the phenotype and response to recombinant human (rh) FSH of a female patient with a novel homozygous loss-of-function mutation of FSHbeta, and to characterize in vitro the molecular mechanisms responsible for the FSH inactivation. PATIENT: METHODS AND RESULTS: Sequencing of the FSHbeta gene revealed a homozygous 1 bp (G) deletion at codon 79 (c.289delG) of exon 3 which produced a frameshift at codon 79 (A79fs108X) and a premature stop codon at codon 109. The wild-type and mutant FSHbeta cDNAs inserted into expression vector were cotransfected into Chinese hamster ovary cells with the alpha-subunit. Wild-type FSH was readily detectable in culture medium, whereas no mutant FSH was detectable by either immunoassay or in vitro bioassay. Mutant FSHbeta protein could not be detected in western blot. In response to a 15-day treatment with rhFSH, sonography revealed multifollicular development in the ovaries. Circulating levels of estradiol and inhibin B were dramatically increased, whereas anti-Mullerian hormone decreased. Serum LH first decreased and then increased, inducing multiovulation associated with supraphysiologic progesterone and inhibin A levels. CONCLUSION: A novel FSHbeta mutation was detected in a hypogonadal woman. rhFSH was effective in ovulation induction in the patient but with signs of ovarian hyperstimulation. The high pretreatment LH levels could contribute to this excessive ovarian response to rhFSH.
|
Authors | Marie-Laure Kottler, Yen-Yin Chou, Olivier Chabre, Nicolas Richard, Camille Polge, Sylvie Brailly-Tabard, Philippe Chanson, Anne Guiochon-Mantel, Ilpo Huhtaniemi, Jacques Young |
Journal | European journal of endocrinology
(Eur J Endocrinol)
Vol. 162
Issue 3
Pg. 633-41
(Mar 2010)
ISSN: 1479-683X [Electronic] England |
PMID | 19966036
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Follicle Stimulating Hormone, beta Subunit
- Recombinant Proteins
- Inhibins
- Follicle Stimulating Hormone
|
Topics |
- Adult
- Amenorrhea
(blood, drug therapy, genetics)
- Animals
- Biological Assay
- Blotting, Western
- Cell Line
- Cells, Cultured
- Cricetinae
- Female
- Follicle Stimulating Hormone
(deficiency, therapeutic use)
- Follicle Stimulating Hormone, beta Subunit
(genetics)
- Humans
- Immunoassay
- Inhibins
(deficiency)
- Mutation
(genetics)
- Ovary
(diagnostic imaging, drug effects)
- Pedigree
- Recombinant Proteins
(therapeutic use)
- Reverse Transcriptase Polymerase Chain Reaction
- Treatment Outcome
- Ultrasonography
|